{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T11:02:22Z","timestamp":1792321342418,"version":"4.4.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Radiation Oncology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.semradonc.2018.06.004","type":"journal-article","created":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T14:19:33Z","timestamp":1539008373000},"page":"351-361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Cholangiocarcinoma and Gallbladder Cases: An Expert Panel Case-Based Discussion"],"prefix":"10.1016","volume":"28","author":[{"given":"Pamela J.","family":"Boimel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim Reiss","family":"Binder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore S.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar","family":"Ben-Josef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 6","key":"10.1016\/j.semradonc.2018.06.004_bib0001","doi-asserted-by":"crossref","DOI":"10.1136\/gut.51.suppl_6.vi1","article-title":"Guidelines for the diagnosis and treatment of cholangiocarcinoma: Consensus document","volume":"51","author":"Khan","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.semradonc.2018.06.004_bib0002","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1200\/JCO.2014.60.2219","article-title":"SWOG S0809: A phase II intergroup trial of adjuvant capecitabine and gemcitabine followed by radiotherapy and concurrent capecitabine in extrahepatic cholangiocarcinoma and gallbladder carcinoma","volume":"33","author":"Ben-Josef","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2018.06.004_bib0003","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.ijrobp.2006.05.061","article-title":"External-beam radiotherapy for localized extrahepatic cholangiocarcinoma","volume":"66","author":"Ben-David","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2018.06.004_bib0004","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00268-002-6434-1","article-title":"Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma","volume":"27","author":"Gerhards","year":"2003","journal-title":"World J Surg"},{"key":"10.1016\/j.semradonc.2018.06.004_bib0005","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0360-3016(99)00472-1","article-title":"Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma","volume":"46","author":"Todoroki","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2018.06.004_bib0006","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/00000658-199403000-00006","article-title":"Carcinoma of the extrahepatic bile ducts. The University of California at San Francisco experience","volume":"219","author":"Schoenthaler","year":"1994","journal-title":"Ann Surg"},{"key":"10.1016\/j.semradonc.2018.06.004_bib0007","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ijrobp.2006.11.048","article-title":"Adjuvant concurrent chemoradiation for adenocarcinoma of the distal common bile duct","volume":"68","author":"Hughes","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2018.06.004_bib0008","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/jamasurg.2013.5137","article-title":"Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: Systematic review and meta-analysis","volume":"149","author":"Mavros","year":"2014","journal-title":"JAMA Surg"},{"key":"10.1016\/j.semradonc.2018.06.004_bib0009","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S1072-7515(01)01016-X","article-title":"Intrahepatic cholangiocarcinoma: Resectability, recurrence pattern, and outcomes","volume":"193","author":"Weber","year":"2001","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.semradonc.2018.06.004_bib0010","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/jso.23605","article-title":"Temporal trends in liver-directed therapy of patients with intrahepatic cholangiocarcinoma in the United States: A population-based analysis","volume":"110","author":"Amini","year":"2014","journal-title":"J Surg Oncol"},{"issue":"15_suppl","key":"10.1016\/j.semradonc.2018.06.004_bib0011","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.35.15_suppl.4006","article-title":"Adjuvant capecitabine for biliary tract cancer: The BILCAP randomized study","volume":"35","author":"Primrose","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2018.06.004_bib0012","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00000658-200110000-00010","article-title":"Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma","volume":"234","author":"Jarnagin","year":"2001","journal-title":"Ann Surg"},{"key":"10.1016\/j.semradonc.2018.06.004_bib0013","doi-asserted-by":"crossref","first-page":"4737","DOI":"10.1002\/cncr.27492","article-title":"The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: A multi-institutional analysis of 305 cases","volume":"118","author":"de Jong","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.semradonc.2018.06.004_bib0014","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/oxfordjournals.annonc.a010676","article-title":"Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer","volume":"7","author":"Glimelius","year":"1996","journal-title":"Ann Oncol"},{"key":"10.1016\/j.semradonc.2018.06.004_bib0015","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semradonc.2018.06.004_bib0016","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/sj.bjc.6603334","article-title":"Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer","volume":"95","author":"Harder","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.semradonc.2018.06.004_bib0017","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/0360-3016(94)90115-5","article-title":"The impact of radiation dose in combined external beam and intraluminal Ir-192 brachytherapy for bile duct cancer","volume":"28","author":"Alden","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2018.06.004_bib0018","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0360-3016(02)02845-6","article-title":"Limitations of conventional doses of chemoradiation for unresectable biliary cancer","volume":"53","author":"Crane","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2018.06.004_bib0019","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0360-3016(98)00509-4","article-title":"Radiotherapy and multimodality management of cholangiocarcinoma","volume":"44","author":"Urego","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2018.06.004_bib0020","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.3748\/wjg.v18.i19.2364","article-title":"Clinical benefit of radiation therapy and metallic stenting for unresectable hilar cholangiocarcinoma","volume":"18","author":"Isayama","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.semradonc.2018.06.004_bib0021","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1200\/JCO.2015.64.2710","article-title":"Multi-institutional phase II study of high-dose hypofractionated proton beam therapy in patients with localized, unresectable hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"34","author":"Hong","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2018.06.004_bib0022","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/sj.bjc.6605779","article-title":"Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan","volume":"103","author":"Okusaka","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.semradonc.2018.06.004_bib0023","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/annonc\/mdh150","article-title":"5-Fluorouracil induces arterial vasocontractions","volume":"15","author":"Sudhoff","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.semradonc.2018.06.004_bib0024","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH699>3.0.CO;2-9","article-title":"Expression of angiogenic factor thymidine phosphorylase and angiogenesis in human atherosclerosis","volume":"192","author":"Boyle","year":"2000","journal-title":"J Pathol"},{"key":"10.1016\/j.semradonc.2018.06.004_bib0025","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/jnci\/91.15.1310","article-title":"Cancer risks in BRCA2 mutation carriers","volume":"91","year":"1999","journal-title":"JNCI"},{"key":"10.1016\/j.semradonc.2018.06.004_bib0026","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.aan6733","article-title":"Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade","volume":"357","author":"Le","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.semradonc.2018.06.004_bib0027","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1634\/theoncologist.2011-0386","article-title":"Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping","volume":"17","author":"Borger","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.semradonc.2018.06.004_bib0028","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.humpath.2014.03.014","article-title":"Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma","volume":"45","author":"Graham","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1016\/j.semradonc.2018.06.004_bib0029","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1007\/s00270-007-9032-7","article-title":"Transarterial chemoembolization (TACE) for inoperable intrahepatic cholangiocarcinoma","volume":"30","author":"Herber","year":"2007","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.semradonc.2018.06.004_bib0030","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s00270-008-9336-2","article-title":"Chemoembolization (TACE) of unresectable intrahepatic cholangiocarcinoma with slow-release doxorubicin-eluting beads: Preliminary results","volume":"31","author":"Aliberti","year":"2008","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.semradonc.2018.06.004_bib0031","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.jvir.2013.02.031","article-title":"Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: Safety, response, and survival analysis","volume":"24","author":"Mouli","year":"2013","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.semradonc.2018.06.004_bib0032","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ejso.2014.09.007","article-title":"Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: A systematic review and pooled analysis","volume":"41","author":"Al-Adra","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.semradonc.2018.06.004_bib0033","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.radonc.2009.11.004","article-title":"Stereotactic body radiotherapy for unresectable cholangiocarcinoma","volume":"94","author":"Kopek","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.semradonc.2018.06.004_bib0034","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1186\/1471-2407-10-492","article-title":"Determining the role of external beam radiotherapy in unresectable intrahepatic cholangiocarcinoma: A retrospective analysis of 84 patients","volume":"10","author":"Chen","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.semradonc.2018.06.004_bib0035","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1200\/JCO.2007.14.3529","article-title":"Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"26","author":"Tse","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2018.06.004_bib0036","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1053\/srao.2001.23485","article-title":"Partial irradiation of the liver","volume":"11","author":"Dawson","year":"2001","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.semradonc.2018.06.004_bib0037","doi-asserted-by":"crossref","first-page":"8739","DOI":"10.1200\/JCO.2005.01.5354","article-title":"Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies","volume":"23","author":"Ben-Josef","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2018.06.004_bib0038","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/jgh.12843","article-title":"Proton beam therapy for unresectable intrahepatic cholangiocarcinoma","volume":"30","author":"Ohkawa","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.semradonc.2018.06.004_bib0039","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1200\/JCO.2011.40.5381","article-title":"Adjuvant therapy in the treatment of biliary tract cancer: A systematic review and meta-analysis","volume":"30","author":"Horgan","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2018.06.004_bib0040","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/SLA.0b013e31806beec2","article-title":"Gallbladder cancer: The role of laparoscopy and radical resection","volume":"245","author":"Shih","year":"2007","journal-title":"Ann Surg"},{"key":"10.1016\/j.semradonc.2018.06.004_bib0041","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1634\/theoncologist.2009-0302","article-title":"Current management of gallbladder carcinoma","volume":"15","author":"Zhu","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.semradonc.2018.06.004_bib0042","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1470-2045(03)01021-0","article-title":"Carcinoma of the gallbladder","volume":"4","author":"Misra","year":"2003","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.semradonc.2018.06.004_bib0043","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1186\/s12885-015-1617-y","article-title":"Adjuvant therapy in the treatment of gallbladder cancer: A meta-analysis","volume":"15","author":"Ma","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.semradonc.2018.06.004_bib0044","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ijrobp.2008.10.052","article-title":"Adjuvant therapy for gallbladder carcinoma: The Mayo clinic experience","volume":"75","author":"Gold","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2018.06.004_bib0045","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0360-3016(01)01764-3","article-title":"Adjuvant external beam radiation therapy with concurrent chemotherapy in the management of gallbladder carcinoma","volume":"52","author":"Kresl","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Seminars in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053429618300493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053429618300493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T18:59:29Z","timestamp":1775242769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053429618300493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S1053429618300493"],"URL":"https:\/\/doi.org\/10.1016\/j.semradonc.2018.06.004","relation":{},"ISSN":["1053-4296"],"issn-type":[{"value":"1053-4296","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cholangiocarcinoma and Gallbladder Cases: An Expert Panel Case-Based Discussion","name":"articletitle","label":"Article Title"},{"value":"Seminars in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semradonc.2018.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}